The most recent listing of current clinical trials for gastrointestinal cancers — including colon, rectal, anal and gastroesophageal — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Gastrointestinal
(Includes Colon, Rectal, Anal
and Gastroesophageal)
| Protocol ID |
|
Title |
|
| E3204 |
|
Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLOFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer
Keywords: Locally Advanced Rectal Cancer |
|
Memorial Sloan Kettering
(also in thoracic) |
|
A Random Assignment Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) versus Parent DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma
Keywords: Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma |
|
| In-House-geriatric |
|
Use of the Comprehensive Geriatric Assessment in Older Colorectal Cancer Patients to Identify Vulnerability and Guide Treatment Choices
Keywords: geriatric colorectal cancer patients |
|
| AB04030 |
|
A Prospective, Multicenter, Randomized, Open-Label, Active Controlled, 2-Parallel Group, Phase III Study to Compare Efficacy and Safety of Masitinib at 7.5 mg/kg/day to Imatinib at 400 or 600mg in Treatment of Patients with Gastro-Intestinal Stromal Tumor in First Line Medical Treatment
Keywords: Patients with Gastro-Intestinal Stromal Tumor in First Line Medical Treatment |
|